Repeat left ventricular-assisted device exchange and upgrade from second- to third-generation devices in a high-volume single center.
Mahwash KassiEleonora AvenattiKhanh-Doan HoangSalma ZookRayan YousafzaiAshrith GuhaArvind BhimarajLin-Chiang Philip ChouErik E SuarezPublished in: Artificial organs (2024)
We report the feasibility and safety of a repeat pump exchange with an upgrade to HMIII in a high-volume center. The decision for medical therapy versus surgical exchange has to be tailored to individual cases based on risk factors and clinical stability but in expert hands, even a re-redo surgical approach grants options for good medium-term outcomes.
Keyphrases
- risk factors
- left ventricular
- healthcare
- heart failure
- preterm infants
- smoking cessation
- hypertrophic cardiomyopathy
- type diabetes
- stem cells
- metabolic syndrome
- aortic valve replacement
- coronary artery disease
- mesenchymal stem cells
- atrial fibrillation
- clinical practice
- decision making
- gestational age
- cardiac resynchronization therapy
- left atrial
- transcatheter aortic valve replacement
- aortic valve
- replacement therapy